Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,323 | -52,521 | -39,605 | -18,802 | -70,641 |
| Depreciation Amortization | 8,890 | 6,784 | 4,208 | 2,121 | 7,149 |
| Income taxes - deferred | -51 | N/A | N/A | N/A | 35 |
| Accounts receivable | -7,265 | -6,367 | -3,137 | -3,214 | -285 |
| Accounts payable and accrued liabilities | 1,148 | 1,262 | 1,104 | -1,945 | 1,193 |
| Other Working Capital | -12,058 | -11,606 | -4,469 | -5,852 | 2,164 |
| Other Operating Activity | 21,760 | 17,133 | 10,337 | 7,934 | 6,889 |
| Operating Cash Flow | $-50,899 | $-45,315 | $-31,562 | $-19,758 | $-53,496 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,000 | 7,000 | 7,000 | 7,000 | -6,774 |
| PPE Investments | -3,653 | -3,059 | -2,227 | -804 | -7,305 |
| Investing Cash Flow | $3,347 | $3,941 | $4,773 | $6,196 | $-14,079 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,250 | N/A | N/A | N/A | 31,250 |
| Debt Repayment | -676 | -496 | -321 | -148 | -621 |
| Common Stock Issued | 346 | 311 | 201 | 58 | 447 |
| Other Financing Activity | 45,924 | 45,952 | 46,028 | -329 | -2,350 |
| Financing Cash Flow | $56,844 | $45,767 | $45,908 | $-419 | $28,726 |
| Beginning Cash Position | 74,532 | 74,532 | 74,532 | 74,532 | 113,381 |
| End Cash Position | 83,824 | 78,925 | 93,651 | 60,551 | 74,532 |
| Net Cash Flow | $9,292 | $4,393 | $19,119 | $-13,981 | $-38,849 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,899 | -45,315 | -31,562 | -19,758 | -53,496 |
| Capital Expenditure | -3,653 | -3,059 | -2,227 | -804 | -7,360 |
| Free Cash Flow | -54,552 | -48,374 | -33,789 | -20,562 | -60,856 |